Until mid-March, Demant reported double-digit organic growth driven by a robust product portfolio. However, COVID-19 led to the closure of hearing clinics across key markets, which severely impacted sales and profits. Currently, Demant is operating at a c.30% revenue run rate. Nonetheless, the fundamentals of the hearing aids industry are still intact and we should see a gradual recovery, which could spill-over into 2021. Until then, the headsets business, which is benefiting from the working
06 May 2020
After a strong start, Demant is operating at 30% run-rate; recovery spill-over into 2021?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
After a strong start, Demant is operating at 30% run-rate; recovery spill-over into 2021?
Until mid-March, Demant reported double-digit organic growth driven by a robust product portfolio. However, COVID-19 led to the closure of hearing clinics across key markets, which severely impacted sales and profits. Currently, Demant is operating at a c.30% revenue run rate. Nonetheless, the fundamentals of the hearing aids industry are still intact and we should see a gradual recovery, which could spill-over into 2021. Until then, the headsets business, which is benefiting from the working